These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2193493

  • 1. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
    Houston MC, Burger C, Hays JT, Nadeau J, Swift L, Bradley CA, Olafsson L.
    Am Heart J; 1990 Jul; 120(1):172-9. PubMed ID: 2193493
    [Abstract] [Full Text] [Related]

  • 2. Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension.
    Houston MC, Olafsson L, Burger MC.
    Angiology; 1991 Sep; 42(9):681-90. PubMed ID: 1928808
    [Abstract] [Full Text] [Related]

  • 3. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E.
    Knopp RH, Walden CE, Warnick GR, Albers JJ, Ginsberg J, McGinnis BM.
    Am J Med; 1987 Nov 27; 83(5B):75-84. PubMed ID: 3120587
    [Abstract] [Full Text] [Related]

  • 4. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A, Himanen P, Saraste M, Niittymäki K, Marniemi J.
    Br J Clin Pharmacol; 1986 Nov 27; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [Abstract] [Full Text] [Related]

  • 5. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM, Creager MA, Gallagher SJ, Loscalzo J, Dzau VJ.
    Am J Med; 1989 Jan 23; 86(1B):8-13. PubMed ID: 2563311
    [Abstract] [Full Text] [Related]

  • 6. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y, Gagné C.
    J Hum Hypertens; 1993 Apr 23; 7(2):149-52. PubMed ID: 8510087
    [Abstract] [Full Text] [Related]

  • 7. Fenofibrate affects the compositions of lipoproteins.
    Goldberg AC, Schonfeld G, Anderson C, Dillingham MA.
    Am J Med; 1987 Nov 27; 83(5B):60-5. PubMed ID: 3318455
    [Abstract] [Full Text] [Related]

  • 8. Lipids and lipoproteins during antihypertensive drug therapy. Comparison of doxazosin and atenolol in a randomized, double-blind trial: the Alpha Beta Canada Study.
    Rabkin SW, Huff MW, Newman C, Sim D, Carruthers SG.
    Hypertension; 1994 Aug 27; 24(2):241-8. PubMed ID: 8039850
    [Abstract] [Full Text] [Related]

  • 9. Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia.
    Superko HR, Wood PD, Krauss RM.
    Am J Med; 1989 Jan 23; 86(1B):26-31. PubMed ID: 2913769
    [Abstract] [Full Text] [Related]

  • 10. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial.
    Middeke M, Weisweiler P, Schwandt P, Holzgreve H.
    Clin Cardiol; 1987 Feb 23; 10(2):94-8. PubMed ID: 3545579
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects.
    Dujovne CA, Eff J, Ferraro L, Goldstein RJ, Gotto AM, Hall WD, Harris WS, Held SJ, Herd A, Hunninghake DB.
    Am J Cardiol; 1993 Nov 15; 72(15):1131-6. PubMed ID: 8237801
    [Abstract] [Full Text] [Related]

  • 12. Diuretics and beta-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Lakshman MR, Reda DJ, Materson BJ, Cushman WC, Freis ED.
    Arch Intern Med; 1999 Mar 22; 159(6):551-8. PubMed ID: 10090111
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients.
    Pollare T, Lithell H, Selinus I, Berne C.
    BMJ; 1989 Apr 29; 298(6681):1152-7. PubMed ID: 2500169
    [Abstract] [Full Text] [Related]

  • 14. Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial.
    Schmitz G, Stumpe KO, Herrmann W, Weidinger G.
    Blood Press; 1996 Nov 29; 5(6):354-9. PubMed ID: 8973753
    [Abstract] [Full Text] [Related]

  • 15. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A, Walldius G, Szamosi A, Dahlen G, de Faire U.
    Circulation; 1986 Jun 29; 73(6):1097-110. PubMed ID: 3698244
    [Abstract] [Full Text] [Related]

  • 16. Studies of lipids, lipoproteins, and apolipoproteins in Menkes' disease.
    Blackett PR, Lee DM, Donaldson DL, Fesmire JD, Chan WY, Holcombe JH, Rennert OM.
    Pediatr Res; 1984 Sep 29; 18(9):864-70. PubMed ID: 6483510
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: a one-year, double-blind study in 228 hypertensive patients.
    Talseth T, Westlie L, Daae L, Vatle S.
    Am Heart J; 1988 Dec 29; 116(6 Pt 2):1790-6. PubMed ID: 2904752
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of beta-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles.
    Vyssoulis GP, Karpanou EA, Pitsavos CE, Skoumas JN, Paleologos AA, Toutouzas PK.
    Eur Heart J; 1992 Nov 29; 13(11):1506-13. PubMed ID: 1361175
    [Abstract] [Full Text] [Related]

  • 19. Effects of arotinolol on serum lipid and apolipoprotein levels in patients with mild essential hypertension.
    Sasaki J, Handa K, Arakawa K.
    Clin Ther; 1989 Nov 29; 11(5):580-3. PubMed ID: 2478285
    [Abstract] [Full Text] [Related]

  • 20. Effects of indoramin and metoprolol on plasma lipids and lipoproteins.
    Martinez TL, Auriemo CR, Machado AM, Cunha MA, Feres MC, Maldjian S, Wortsman A, Delboni FO.
    J Cardiovasc Pharmacol; 1986 Nov 29; 8 Suppl 2():S76-9. PubMed ID: 2423803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.